Single-incision transumbilical laparoscopic Roux-en-Y gastric bypass

ISRCTN ISRCTN92780988
DOI https://doi.org/10.1186/ISRCTN92780988
Secondary identifying numbers EMRP17098N
Submission date
27/09/2010
Registration date
07/10/2010
Last edited
07/10/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Chih-Kun Huang
Scientific

Yi-Da Road
Kaohsiung County
824
Taiwan

Study information

Study designProspective non-randomised controlled study
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleSingle-incision transumbilical laparoscopic Roux-en-Y gastric bypass: a prospective non-randomised controlled study
Study objectives1. To evaluate the feasibility and safety of single-incision transumbilical laparoscopic Roux-en-Y gastric bypass
2.To compare the surgical outcome of the single incision transumbilical and 5-ports laparoscopic Roux-en-Y gastric bypass
Ethics approval(s)E-Da Institutional Review Board (IRB) approved on the 13th August 2009 (ref: EMRP17098N)
Health condition(s) or problem(s) studiedMorbid obesity/type II diabetes meliitus
InterventionThe study prospectively compares single incision transumbilical laparoscopic Roux en Y gastric bypass (intervention arm) and conventional 5-port laparoscopic Roux en Y gastric bypass (control arm). Patients can choose which surgery they prefer for themselves. The total duration for treatment is 2 years and all patients are followed 2 years.
Intervention typeOther
Primary outcome measureMeasured peri-operatively and 3 months post-operatively:
1. Operation time
2. Intra-operative complication
3. Post-operative complication
4. Analgesic use
5. Hospitalisation
Secondary outcome measures1. Excess weight loss in first year, measured at 1, 3, 6, 9 and 12 months
2. Wound satisfaction, measured at 3 months
Overall study start date01/11/2008
Completion date31/12/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants100 patients
Key inclusion criteriaAll patients (aged 18 - 65 years, either sex) considered for laparoscopic Roux-en-Y gastric bypass as the treatment method for morbid obesity or Type II Diabetes mellitus
Key exclusion criteria1. Body mass index (BMI) greater than 50
2. Body height greater than 180 cm
Date of first enrolment01/11/2008
Date of final enrolment31/12/2010

Locations

Countries of recruitment

  • Taiwan

Study participating centre

Yi-Da Road
Kaohsiung County
824
Taiwan

Sponsor information

E-Da Hospital (Taiwan)
Hospital/treatment centre

1 Yi-Da Road
Kaohsiung County
824
Taiwan

Website http://www.edah-hospital.com
ROR logo "ROR" https://ror.org/00eh7f421

Funders

Funder type

Hospital/treatment centre

E-Da Hospital (Taiwan)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan